Searchable abstracts of presentations at key conferences in endocrinology

ea0029p820 | Endocrine tumours and neoplasia | ICEECE2012

Medical and Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Well and Moderately Differentiated Neuroendocrine Tumours

Bianchi A. , Iacovazzo D. , Lugli F. , Fusco A. , Chiloiro S. , Mormando M. , Tartaglione L. , Grande G. , Larghi A. , Schinzari G. , Doglietto G. , Margaritora S. , Perotti G. , Rindi G. , Pontecorvi A. , De Marinis L.

Introduction: Peptide receptor radionuclide therapy (PRRT) is a treatment choice for inoperable or metastasized neuroendocrine tumours and this therapy seems more effective in the biochemical and volume control of disease than somatostatin analogues (SSA).Aims: To demonstrate the efficacy of medical therapy with SSA and PRRT in patients with well and moderately differentiated neuroendocrine tumours.Materials and methods: We evaluat...

ea0029p844 | Endocrine tumours and neoplasia | ICEECE2012

Establishment of a Multidisciplinary Tumor Board for Patients with Neuroendocrine Neoplasms

Bianchi A. , Iacovazzo D. , Plastino F. , Lugli F. , Pontecorvi A. , Doglietto G. , Giordano A. , Barone C. , De Marinis L. , Rindi G.

Introduction: Neuroendocrine neoplasms are rare and multiform requiring a multidisciplinary approach. We report the experience of a Neuroendocrine tumor board (TB) established at our University Hospital.Aims: The aim is to share clinical and diagnostic data for best decision-making according to the existing ENETS guidelines.Materials and methods: According to the indications for ENETS Centers of Excellence, meetings with experts in...

ea0029p847 | Endocrine tumours and neoplasia | ICEECE2012

Clinical and morphological characterization of C cell hyperplastic and neoplastic lesions of thyroid

Lugli F. , Fusco A. , Bianchi A. , Milardi D. , Cimino V. , Piacentini S. , Celico M. , Lanza P. , Raffaelli M. , Lombardi C. , Fadda G. , Bellantone R. , Pontecorvi A. , Rindi G. , De Marinis L.

Introduction: Medullary thyroid carcinoma (MTC) and C cell hyperplasia (CCH) have a variable clinical presentation and prognosis and few data are available on the correlation between immunohistochemical characterization (IIC) and clinical behavior.Aim: We studied the clinical and morphological characterization of CCH and MTC and we evaluated IIC expression of PTTG-1, SSTR2A, VEGFR-1, VEGFR-2 and VEGFR-3 in 23 cases of CCH and/or MTC, correlating it with ...